Back to News
Market Impact: 0.45

Nurix Therapeutics Posts Wider Loss In Q1

NRIX
Corporate EarningsHealthcare & BiotechCompany Fundamentals

Nurix reported Q1 net loss of $87.2M ($0.79/sh) versus $56.4M ($0.67/sh) a year ago, a ~55% widening of the loss. Revenue fell to $6.3M from $18.5M a year earlier, down ~66%, signaling a material top-line deterioration that is likely to pressure the stock.

Analysis

Nurix reported Q1 net loss of $87.2M ($0.79/sh) versus $56.4M ($0.67/sh) a year ago, a ~55% widening of the loss. Revenue fell to $6.3M from $18.5M a year earlier, down ~66%, signaling a material top-line deterioration that is likely to pressure the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly negative

Sentiment Score

-0.70

Ticker Sentiment

NRIX-0.80